# Spain Extracorporeal Membrane Oxygenation Machine Market

> Spain Extracorporeal Membrane Oxygenation Machine Market Research Report By Application (Cardiac Support, Respiratory Support, Cardiopulmonary Bypass), By End User (Hospitals, Ambulatory Surgical Centers, Home Care Settings), By Product Type (Venoarterial ECMO, Venovenous ECMO, Arteriovenous ECMO) andBy Component (Membrane Oxygenator, Blood Pumps, Heat Exchangers) - Growth & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 6.15%
- **2024:** $ 27.95 Million
- **2025:** $ 29.67 Million
- **2035:** $ 53.91 Million
- **Key Players:** Medtronic (US), Getinge (SE), LivaNova (GB), Fresenius SE (DE), Terumo Corporation (JP), Maquet (DE), Nipro Corporation (JP), Xenios AG (DE)

**Report ID:** MRFR/MED/49079-HCR · **Pages:** 200 · **Author:** Rahul Gotadki & Garvit Vyas · **Last Updated:** April 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/spain-extracorporeal-membrane-oxygenation-machine-market-50836

---

## Market Summary

## **Spain Extracorporeal Membrane Oxygenation Machine Market Overview**

As per MRFR analysis, the Spain Extracorporeal Membrane Oxygenation Machine Market Size was estimated at 39.6 (USD Million) in 2023. The Spain Extracorporeal Membrane Oxygenation Machine Market Industry is expected to grow from 41.85(USD Million) in 2024 to 94.3 (USD Million) by 2035. The Spain Extracorporeal Membrane Oxygenation Machine Market CAGR (growth rate) is expected to be around 7.665% during the forecast period (2025 - 2035).

### Key Spain Extracorporeal Membrane Oxygenation Machine Market Trends Highlighted

The Spain Extracorporeal Membrane Oxygenation (ECMO) Machine Market is witnessing significant growth driven by several key market drivers. One major driver is the increasing prevalence of respiratory diseases and cardiac failures within the country, leading to a greater demand for advanced life support systems that can provide critical care to patients.

The Spanish government has emphasized enhancing healthcare infrastructure, which includes the provision of state-of-the-art medical equipment like ECMO machines in facilities across the nation. This government commitment is further supported by initiatives aimed at expanding healthcare access, especially in remote areas, thereby improving patient outcomes.

The increasing emphasis on the integration of technology in healthcare presents opportunities for innovation in terms of explorable opportunities. The efficiency of patient care can be considerably improved by the development of portable and automated ECMO systems, which will make these devices more accessible for emergency scenarios and improve overall treatment capabilities.

Local manufacturers can collaborate with hospitals to develop customised solutions that address specific requirements, given Spain's substantial emphasis on healthcare research and development. Recent trends suggest a transition to more efficient training programs for healthcare professionals when it comes to ECMO operation. This trend is essential for guaranteeing that medical personnel can effectively operate these intricate devices, which is particularly important given the intense nature of patient care during emergencies.

Furthermore, the significance of ECMO in the treatment of grievous patients is becoming increasingly acknowledged as Spain enhances its public health strategies, thereby promoting further investment in this technology and raising awareness. The incorporation of ECMO machines will be a critical component of Spain's healthcare landscape as hospitals and healthcare systems continue to develop, thereby improving patient management capabilities.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **Spain Extracorporeal Membrane Oxygenation Machine Market Drivers**

### **Increasing incidence of respiratory diseases**

The rising prevalence of respiratory diseases in Spain is a primary driver for the growth of the Spain Extracorporeal Membrane Oxygenation Machine Market Industry. According to data from the Spanish Society of Pulmonology and Thoracic Surgery, chronic respiratory diseases affect nearly 10% of the population in Spain with a projected annual increase of around 3% over the past five years.

This increase correlates with a heightened demand for advanced medical interventions, including Extracorporeal Membrane Oxygenation (ECMO) machines, particularly during critical conditions such as Acute Respiratory Distress Syndrome (ARDS) linked to various factors including environmental conditions and lifestyle diseases.

The implementation of updated healthcare policies aimed at treating respiratory diseases has led to the acquisition of ECMO machines in hospitals across Spain, notably in urban areas with high pollution levels. As hospitals invest in advanced technologies to manage these chronic diseases more effectively, the ECMO market is expected to expand significantly.

Major healthcare institutions, such as Hospital Universitario La Paz, are actively investing in such technologies to enhance patient outcomes, showcasing the growing integration of ECMO systems in modern respiratory care.

### **Advancements in healthcare technology**

The rapid advancement in medical technology significantly drives the Spain Extracorporeal Membrane Oxygenation Machine Market Industry. The continuous innovation in ECMO machines, including better compatibility, ease of use, and enhanced functionalities, has increased their adoption in hospitals.

The Spanish Ministry of Health reported a surge in technology integration within healthcare systems, especially following the COVID-19 pandemic, which emphasized the necessity for improved life-supporting technologies.

Hospitals in Spain are now focusing on acquiring state-of-the-art ECMO systems that offer better patient support and are backed by extensive Research and Development efforts. Companies such as Maquet and Abbott have made significant contributions by introducing technologically advanced ECMO machines that are tailored to meet the specific needs of intensive care units.

This advancement not only improves patient survival rates but also encourages hospitals to invest more in these machines.

### **Government support and healthcare funding**

Government initiatives and increased healthcare funding in Spain are crucial in propelling the Spain Extracorporeal Membrane Oxygenation Machine Market Industry. The Spanish government has prioritized healthcare investments, allocating significant budgetary resources to improve hospital infrastructure and medical equipment procurement.

For instance, the latest reports indicate that the Spanish Ministry of Health aims to increase healthcare expenditure by approximately 7% annually over the next few years. This funding expansion directly impacts the acquisition of critical life-saving technologies, including ECMO machines, as hospitals strive to enhance their service quality and meet rising patient demands.

Furthermore, the health reforms set by Spain's government stress the importance of life support systems, creating an environment conducive to the growth of the ECMO market. Important healthcare bodies like the National Health System are also advocating for the adoption of more advanced technologies to improve emergency care services.

### **Growing awareness and education around ECMO procedures**

Increasing awareness and training regarding ECMO and its benefits have significantly contributed to the growth of the Spain Extracorporeal Membrane Oxygenation Machine Market Industry. Educational programs by medical institutions and healthcare organizations have emphasized the importance of ECMO in critical care settings.

According to recent findings presented in professional medical forums, there has been a 30% rise in training programs for healthcare professionals focused on ECMO procedures in Spain. Notable institutions, including the Spanish Society of Intensive Care Medicine, have taken leading roles in organizing workshops and seminars to disseminate knowledge about ECMO use, outcome improvements, and best practices.

This enhanced understanding among healthcare professionals leads to better decision-making when utilizing ECMO technologies, ultimately driving higher demand within the healthcare sector as more institutions embrace the procedure.

## **Spain Extracorporeal Membrane Oxygenation Machine Market Segment Insights**

### **Extracorporeal Membrane Oxygenation Machine Market Application Insights**

The Spain Extracorporeal Membrane Oxygenation Machine Market is experiencing steady growth, particularly within the Application segment, which plays a vital role in various clinical settings. This segment broadens its significance as it covers crucial therapies aimed at patients with severe heart and lung conditions. Within this expansive area, Cardiac Support holds a prominent place, serving critically ill patients facing life-threatening cardiac issues, thereby reinforcing its criticality in emergency and high-dependency units.

Respiratory Support is another essential component of the market, obtaining importance due to the surge in respiratory diseases and the increasing need for advanced therapeutic solutions to improve patient outcomes. It meets the growing demand for sophisticated interventions in conditions like acute respiratory distress syndrome, further accentuating the need for Extracorporeal Membrane Oxygenation machines equipped to address these challenges.

Meanwhile, Cardiopulmonary Bypass remains a significant aspect, particularly during surgical procedures aiming at addressing complex cardiac problems. The advancement of these devices offers more effective solutions to manage patients during surgery, thereby enhancing overall surgical results. The market segmentation allows healthcare providers to tailor their approaches based on specific patient needs, leading to improved treatment efficiency and enhanced survival rates.

As Spain prioritizes the modernization of its healthcare infrastructure and acknowledges the rising prevalence of chronic diseases, the significance of the Spain Extracorporeal Membrane Oxygenation Machine Market continues to evolve. The ongoing innovation and technological advancements within this Application segment promise to address the burgeoning healthcare demands and foster better clinical outcomes for patients across the nation.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

### **Extracorporeal Membrane Oxygenation Machine Market End User Insights**

The End User segment of the Spain Extracorporeal Membrane Oxygenation Machine Market plays a vital role in the overall framework of patient care, with a particular focus on Hospitals, Ambulatory Surgical Centers, and Home Care Settings. Hospitals are leading users of extracorporeal membrane oxygenation systems, as they require sophisticated technology for critically ill patients needing advanced cardiovascular support.

Ambulatory Surgical Centers are also gaining traction due to the growing trend of outpatient surgeries and the need for efficient postoperative respiratory management, reflecting the evolution of care pathways. Home Care Settings are emerging as significant contributors to this market, driven by the rising preference for home-based healthcare solutions, especially among chronic patients, leading to increased acceptance of advanced medical devices in domestic environments.

The diverse nature of these end users underlines the demand for tailored ECMO solutions, presenting opportunities for innovation and development in the Spain Extracorporeal Membrane Oxygenation Machine Market. Moreover, demographic shifts and an aging population further support the growth and importance of these segments, indicating an ever-expanding landscape of healthcare needs and technologies in Spain.

### **Extracorporeal Membrane Oxygenation Machine Market Product Type Insights**

The Spain Extracorporeal Membrane Oxygenation Machine Market exhibits diverse product types, which are critical in addressing various clinical needs. Venoarterial ECMO plays a significant role in patients with severe cardiac and respiratory failure, providing vital support during life-threatening situations. Its capability to deliver both cardiac and respiratory support makes it an essential choice in critical care facilities across Spain.

Venovenous ECMO, on the other hand, predominantly caters to individuals with severe respiratory failure, allowing a more targeted approach to oxygenation without impacting hemodynamics, making it increasingly popular in medical practices. Meanwhile, Arteriovenous ECMO is utilized less frequently but still holds importance in specific therapeutic scenarios, particularly for patients with unique conditions that require specialized care.

The rising prevalence of respiratory diseases and cardiac complications in Spain drives demand for these machines, with healthcare providers seeking advanced solutions to enhance patient outcomes. Each of these product types is integral to the overall functioning of Extracorporeal Membrane Oxygenation solutions, reflecting the evolution and sophistication of respiratory and cardiac support technologies in the market.

### **Extracorporeal Membrane Oxygenation Machine Market Component Insights**

The Spain Extracorporeal Membrane Oxygenation Machine Market showcases a variety of components that play crucial roles in its functionality. The Membrane Oxygenator is a vital part of the system, responsible for gas exchange, and is essential for providing adequate oxygen supply to patients with severe respiratory or cardiac failure.

Following this, Blood Pumps are indispensable for maintaining blood circulation during treatments, ensuring that blood flows effectively through the circuit and minimizing the risk of complications. Furthermore, Heat Exchangers are important for regulating blood temperature during procedures, contributing to patient stability.

The synergy between these components greatly enhances the efficacy of ECMO procedures in Spain, particularly as the demand for advanced medical technologies has been rising due to increasing incidents of heart and lung diseases. Additionally, advancements in technology and engineering in the Spanish medical device sector are driving innovations in these components, leading to improved performance and patient outcomes.

The focus on developing high-quality, reliable components is crucial for meeting the challenges posed by complex medical cases, presenting significant opportunities for growth and market expansion.

## **Spain Extracorporeal Membrane Oxygenation Machine Market Key Players and Competitive Insights**

The Spain Extracorporeal Membrane Oxygenation Machine Market is characterized by its dynamic landscape, where multiple stakeholders compete through various strategies to enhance their market footholds. Extracorporeal Membrane Oxygenation (ECMO) machines play a crucial role in critical care settings, particularly for patients experiencing severe respiratory or cardiac failure.

In this environment, companies are investing in advanced technology, emphasizing quality, regulatory compliance, and customer service to differentiate their offerings. As the demand for these life-saving devices continues to grow amid increased awareness of their applications, competitive strategies also focus on innovation, after-sales support, and establishing partnerships with healthcare institutions to achieve a competitive edge.

A significant component of this market strategy includes understanding local regulations and tailoring products to fit the specific needs of Spanish healthcare systems, thus becoming essential for companies aiming to thrive in this sector.

Bank of America has established a significant presence in the Spain Extracorporeal Membrane Oxygenation Machine Market through strategic financial services tailored to healthcare providers. The company leverages its vast experience in financing and structured funding solutions, which are crucial for hospitals seeking to acquire advanced ECMO technology.

The strength of Bank of America lies in its robust financial capacity, allowing for flexible financing solutions that can help healthcare facilities manage capital expenditures effectively. Their strong relationships with healthcare institutions enable them to understand market needs, subsequently influencing their financial products that cater directly to the evolving landscape of medical equipment investments within Spain. Importantly, their focus on customer-centric services and thorough market knowledge places them favorably within the sector.

On the other hand, LivaNova stands out as a prominent player in the Spain Extracorporeal Membrane Oxygenation Machine Market, known for its innovative medical technology solutions. The company focuses on developing high-quality medical devices and therapies, and its ECMO products are recognized for their reliability and advanced features.

LivaNova has expanded its market presence in Spain through various strategic initiatives, including partnerships with local hospitals and participation in healthcare events that showcase their products. Among their strengths is a strong emphasis on research and development which results in cutting-edge technology, making their ECMO systems highly competitive.

In recent years, LivaNova has pursued mergers and acquisitions to bolster its product portfolio and enhance its capabilities in the ECMO market, thereby positioning itself as a leader in delivering advanced healthcare interventions within Spain. Their comprehensive product offerings and commitment to improving patient outcomes highlight LivaNova’s influential role in the Spanish ECMO market.

### **Key Companies**

## **Spain Extracorporeal Membrane Oxygenation Machine Market Industry Developments**

The Spain Extracorporeal Membrane Oxygenation Machine Market has seen notable developments in recent months, particularly in response to increased demand for advanced respiratory support systems amidst healthcare challenges. Companies like LivaNova and Medtronic have been actively enhancing their product offerings and expanding their market reach.

In terms of mergers and acquisitions, there have been significant movements within the sector. For instance, in June 2023, Fresenius Medical Care completed the acquisition of a regional competitor, strengthening its foothold in the Spanish market. Additionally, in February 2023, Terumo Corporation announced a strategic partnership with Beth Israel Deaconess Medical Center to collaborate on innovative ECMO solutions, further driving advancements in patient care.

The current valuation of the market is on an upward trend, driven by technological advancements and a growing emphasis on improving emergency medical services across Spain. A two-year reflection shows that in March 2022, Getinge launched a new ECMO machine specifically designed for paediatric patients, showcasing the increasing focus on specialized care.

As such, the market is responding positively to evolving healthcare needs and an aging population in Spain, creating a fertile environment for growth and innovation in the ECMO segment.

## **Spain Extracorporeal Membrane Oxygenation Machine Market Segmentation Insights**

### **Extracorporeal Membrane Oxygenation Machine Market Application Outlook**

### **Extracorporeal Membrane Oxygenation Machine Market End User Outlook**

### **Extracorporeal Membrane Oxygenation Machine Market Product Type Outlook**

### **Extracorporeal Membrane Oxygenation Machine Market Component Outlook**

## Market Drivers

### Investment in Healthcare Infrastructure

Spain's ongoing investment in healthcare infrastructure plays a pivotal role in the growth of the extracorporeal membrane-oxygenation-machine market. The government has allocated substantial funds to enhance medical facilities, particularly in critical care units. This investment is aimed at improving patient care and ensuring that hospitals are equipped with the latest technologies. As a result, the demand for ECMO machines is expected to increase, as these devices are essential for managing severe respiratory and cardiac conditions. Furthermore, the establishment of specialized centers for ECMO treatment is likely to emerge, fostering a more robust ecosystem for advanced medical care. This strategic focus on healthcare infrastructure is anticipated to create a favorable environment for the expansion of the extracorporeal membrane-oxygenation-machine market.

### Increasing Incidence of Respiratory Diseases

The rising prevalence of respiratory diseases in Spain is a crucial driver for the extracorporeal membrane-oxygenation-machine market. Conditions such as chronic obstructive pulmonary disease (COPD) and pneumonia are becoming more common, necessitating advanced medical interventions. According to health statistics, respiratory diseases account for a significant portion of hospital admissions, leading to an increased demand for extracorporeal membrane oxygenation (ECMO) systems. The ability of ECMO machines to provide life-saving support in critical situations enhances their importance in healthcare settings. As hospitals strive to improve patient outcomes, the adoption of ECMO technology is likely to rise, thereby propelling market growth. This trend indicates a shift towards more sophisticated treatment options, reflecting the evolving landscape of respiratory care in Spain.

### Collaborations and Partnerships in Healthcare

Collaborations and partnerships among healthcare institutions, technology providers, and research organizations are emerging as a significant driver for the extracorporeal membrane-oxygenation-machine market. These alliances facilitate the sharing of knowledge, resources, and expertise, ultimately enhancing the development and implementation of ECMO technology. In Spain, hospitals are increasingly forming partnerships to establish specialized ECMO centers, which can provide comprehensive care for patients requiring advanced respiratory support. Such collaborations may also lead to innovations in ECMO machine design and functionality, further boosting market growth. The synergy created through these partnerships is likely to foster a more integrated approach to critical care, positioning the extracorporeal membrane-oxygenation-machine market for sustained expansion.

### Rising Awareness of Advanced Treatment Options

There is a growing awareness among healthcare professionals and patients regarding the benefits of advanced treatment options, including extracorporeal membrane-oxygenation machines. This heightened awareness is driving demand for ECMO technology in Spain, as medical practitioners recognize its potential to save lives in critical situations. Educational initiatives and training programs are being implemented to familiarize healthcare providers with ECMO procedures, further promoting its adoption. As more hospitals integrate ECMO into their treatment protocols, the market is expected to expand. This trend indicates a shift towards embracing innovative medical technologies, reflecting a broader commitment to improving patient care and outcomes in the extracorporeal membrane-oxygenation-machine market.

### Aging Population and Associated Health Challenges

The demographic shift towards an aging population in Spain is significantly influencing the extracorporeal membrane-oxygenation-machine market. Older adults are more susceptible to chronic illnesses, including heart and lung diseases, which often require advanced medical interventions. As the population aged 65 and above continues to grow, the demand for ECMO technology is likely to rise. This demographic trend suggests that healthcare providers will increasingly rely on ECMO machines to manage complex cases effectively. Additionally, the aging population may lead to higher healthcare expenditures, prompting hospitals to invest in state-of-the-art equipment. Consequently, the extracorporeal membrane-oxygenation-machine market is poised for growth as it aligns with the evolving healthcare needs of an older demographic.

## Future Outlook

The [Extracorporeal Membrane Oxygenation Machine Market](https://www.marketresearchfuture.com/reports/extracorporeal-membrane-oxygenation-machine-market-8119) in Spain is projected to grow at a 6.15% CAGR from 2025 to 2035, driven by technological advancements and increasing healthcare demands.

**New opportunities:**

- Development of portable ECMO devices for emergency medical services.
- Partnerships with hospitals for ECMO training programs.
- Expansion into telemedicine solutions for remote ECMO monitoring.

By 2035, the market is expected to achieve substantial growth, enhancing patient care and operational efficiency.

## Segment Insights

### By Application: Cardiac Support (Largest) vs. Respiratory Support (Fastest-Growing)

Within the application segment of the Spain extracorporeal membrane-oxygenation-machine market, Cardiac Support maintains the largest market share due to its critical role in managing severe cardiac conditions. This segment benefits from increasing incidence rates of heart diseases and advancements in technology that enhance machinery effectiveness. Meanwhile, Respiratory Support is rapidly gaining traction, driven by the rising prevalence of respiratory disorders and improved awareness regarding ECMO's significant advantages in treating such ailments.

The growth trends for these applications are closely tied to technological enhancements and the increasing focus on patient outcomes. The demand for Cardiac Support equipment is expected to remain strong, largely due to a burgeoning elderly population and a greater number of cardiac procedures performed. Conversely, the Respiratory Support segment is on a faster-growing trajectory, propelled by a surge in respiratory illnesses, particularly post-pandemic, highlighting its potential for further expansion in the coming years.

Cardiac Support (Dominant) vs. Respiratory Support (Emerging)

Cardiac Support stands out as the dominant application within the Spain extracorporeal membrane-oxygenation-machine market, primarily due to its extensive utilization in cardiac surgeries and rescue scenarios. The reliability and efficiency of ECMO machines in critical care settings reinforce this position. On the other hand, Respiratory Support is positioned as an emerging player, gaining momentum from the heightened focus on treating patients with severe respiratory conditions. The innovation and versatility of ECMO machines in facilitating respiratory care cannot be overlooked, as they provide life-saving treatment options, thus paving the way for significant growth in this segment.

### By End User: Hospitals (Largest) vs. Ambulatory Surgical Centers (Fastest-Growing)

In the Spain extracorporeal membrane-oxygenation-machine market, hospitals represent the dominant segment, capturing a substantial share of the overall market. Ambulatory surgical centers are increasingly gaining traction, driven by their ability to offer advanced medical services in a more accessible setting. Home care settings, while present, currently hold a smaller portion of the market, indicating potential growth opportunities in home-based medical services. 

The growth trends indicate a rising demand for extracorporeal membrane-oxygenation machines in hospitals, primarily due to the increasing incidence of respiratory diseases and the need for advanced life support. Ambulatory surgical centers are emerging as the fastest-growing segment, spurred by the push for outpatient procedures and efficient healthcare delivery. Home care settings are expected to expand as more patients seek treatment alternatives outside traditional healthcare facilities.

Hospitals (Dominant) vs. Ambulatory Surgical Centers (Emerging)

The hospitals segment is characterized by established infrastructure and a comprehensive range of services, making it the dominant force in the market. Hospitals are equipped with advanced technology and a skilled workforce capable of handling complex cases requiring extracorporeal membrane-oxygenation machines. On the other hand, ambulatory surgical centers are emerging with innovative care models that prioritize patient convenience and lower costs. These centers focus on less invasive procedures and shorter recovery times, appealing to a growing demographic seeking outpatient care. As both segments evolve, the competition between them may lead to further advancements in patient care and technology adoption.

### By Product Type: Venoarterial ECMO (Largest) vs. Venovenous ECMO (Fastest-Growing)

In the Spain extracorporeal membrane-oxygenation-machine market, the segmentation reveals that Venoarterial ECMO holds the largest market share, primarily due to its extensive application in treating cardiac issues. Venovenous ECMO, while currently smaller in market share, is gaining traction significantly. The specific demand for Venoarterial ECMO is bolstered by its established efficacy and continuous advancements in technology, making it a reliable choice among healthcare providers.

On the other hand, the growth trend for Venovenous ECMO is notable as it expands into new clinical applications, particularly in respiratory failure cases. Factors driving this growth include increased awareness and training among clinicians, advancements in patient selection criteria, and the rising prevalence of conditions requiring ECMO support. As a result, the market is witnessing a shift towards these innovative solutions, reflecting changing patient needs and clinical practices.

Venoarterial ECMO (Dominant) vs. Venovenous ECMO (Emerging)

Venoarterial ECMO remains the dominant force within the Spain extracorporeal membrane-oxygenation-machine market, characterized by its critical role in providing cardiac support. Its robust framework allows for effective treatment of severe cardiac and respiratory conditions, ensuring improved patient outcomes. Conversely, Venovenous ECMO is emerging as a viable alternative, particularly effective in patients with severe respiratory failure. This segment benefits from expanding clinical indications and is increasingly adopted in specialized centers. The competitive landscape indicates a rising focus on enhancing Venovenous ECMO technologies, potentially altering market dynamics as healthcare institutions seek out more varied treatment options.

### By Component: Membrane Oxygenator (Largest) vs. Blood Pumps (Fastest-Growing)

The Spain extracorporeal membrane-oxygenation-machine market shows a significant distribution in market share among its component values. The Membrane Oxygenator holds the largest share, underscoring its essential role in oxygenation processes within ECMO systems. Meanwhile, Blood Pumps are emerging as a critical component, showcasing a rapid increase in demand due to advancements in technology and clinical practices. Heat Exchangers, while vital, currently represent a smaller fraction of the market, primarily complementing the other two components in enhancing overall system efficiency.

Growth trends within the Spain extracorporeal membrane-oxygenation-machine market indicate a robust trajectory, particularly for Blood Pumps which are recognized as the fastest-growing segment. This growth is propelled by innovations in pump designs aimed at improving patient outcomes and operational efficacy. The Membrane Oxygenator's dominance continues to be driven by rising adoption rates in critical care settings. Enhanced focus on patient safety and performance optimization is further contributing to the expansion of these segments, fostering a competitive landscape in the market.

Membrane Oxygenator (Dominant) vs. Blood Pumps (Emerging)

The Membrane Oxygenator serves as the dominant element in the Spain extracorporeal membrane-oxygenation-machine market, critical for providing effective oxygenation and carbon dioxide removal in patients requiring ECMO support. Its widespread use is attributed to its reliability and efficiency, making it a preferred choice in critical care environments. On the other hand, Blood Pumps represent an emerging trend, gaining traction due to their innovative features designed to enhance flow rates and reduce complications during ECMO procedures. The design advancements in Blood Pumps are tailored to support a wider range of patient needs, positioning them as a vital component for future market growth. Both segments are crucial, yet they cater to different aspects of patient care in ECMO applications.

## Competitive Benchmarking

The extracorporeal membrane-oxygenation-machine market in Spain exhibits a dynamic competitive landscape characterized by rapid technological advancements and a growing emphasis on patient-centric solutions. Key players such as Medtronic (US), Getinge (SE), and LivaNova (GB) are at the forefront, leveraging innovation and strategic partnerships to enhance their market positions. Medtronic (US) focuses on integrating advanced digital technologies into its ECMO systems, aiming to improve patient outcomes and streamline clinical workflows. Meanwhile, Getinge (SE) emphasizes sustainability in its operations, aligning with global trends towards environmentally responsible healthcare solutions. LivaNova (GB) appears to be concentrating on expanding its product portfolio through strategic acquisitions, thereby enhancing its competitive edge in the market.
The market structure is moderately fragmented, with several players vying for market share. Key business tactics include localizing manufacturing to reduce costs and optimize supply chains, which is particularly relevant in the current economic climate. The collective influence of these major companies shapes the competitive environment, as they continuously adapt to changing regulatory landscapes and evolving customer needs.
In September 2025, Medtronic (US) announced a partnership with a leading Spanish hospital network to implement its latest ECMO technology, which is expected to enhance patient care and operational efficiency. This strategic move not only reinforces Medtronic's commitment to innovation but also positions the company as a leader in the Spanish market, potentially increasing its market share significantly.
In August 2025, Getinge (SE) launched a new line of ECMO machines designed with enhanced energy efficiency and reduced environmental impact. This initiative aligns with the growing demand for sustainable healthcare solutions and reflects Getinge's strategic focus on environmental responsibility. Such advancements may attract healthcare providers looking to improve their sustainability profiles while maintaining high-quality patient care.
In October 2025, LivaNova (GB) completed the acquisition of a smaller competitor specializing in ECMO technology, which is anticipated to bolster its product offerings and market presence in Spain. This acquisition is likely to enhance LivaNova's competitive positioning by providing access to innovative technologies and expanding its customer base.
As of November 2025, the competitive trends in the extracorporeal membrane-oxygenation-machine market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence. Strategic alliances among key players are shaping the landscape, fostering innovation and enhancing operational efficiencies. The shift from price-based competition to a focus on technological advancement and supply chain reliability is evident, suggesting that future competitive differentiation will hinge on the ability to innovate and respond to the evolving needs of healthcare providers.

## Recent News & Developments

The Spain Extracorporeal Membrane Oxygenation Machine Market has seen notable developments in recent months, particularly in response to increased demand for advanced respiratory support systems amidst healthcare challenges. Companies like LivaNova and Medtronic have been actively enhancing their product offerings and expanding their market reach.

In terms of mergers and acquisitions, there have been significant movements within the sector. For instance, in June 2023, Fresenius Medical Care completed the acquisition of a regional competitor, strengthening its foothold in the Spanish market. Additionally, in February 2023, Terumo Corporation announced a strategic partnership with Beth Israel Deaconess Medical Center to collaborate on innovative ECMO solutions, further driving advancements in patient care.

The current valuation of the market is on an upward trend, driven by technological advancements and a growing emphasis on improving emergency medical services across Spain. A two-year reflection shows that in March 2022, Getinge launched a new ECMO machine specifically designed for paediatric patients, showcasing the increasing focus on specialized care.

As such, the market is responding positively to evolving healthcare needs and an aging population in Spain, creating a fertile environment for growth and innovation in the ECMO segment.

## Report Scope

| MARKET SIZE 2024 | 27.95(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 29.67(USD Million) |
| MARKET SIZE 2035 | 53.91(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 6.15% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Medtronic (US), Getinge (SE), LivaNova (GB), Fresenius SE (DE), Terumo Corporation (JP), Maquet (DE), Nipro Corporation (JP), Xenios AG (DE) |
| Segments Covered | Application, End User, Product Type, Component |
| Key Market Opportunities | Advancements in technology and regulatory support enhance growth potential in the extracorporeal membrane-oxygenation-machine market. |
| Key Market Dynamics | Rising demand for extracorporeal membrane-oxygenation machines driven by advancements in technology and regulatory support in Spain. |
| Countries Covered | Spain |

## Frequently Asked Questions

**Q: What is the current valuation of the extracorporeal membrane-oxygenation-machine market in Spain?**
A: The market valuation was $27.95 Million in 2024.

**Q: What is the projected market valuation for the extracorporeal membrane-oxygenation-machine market in Spain by 2035?**
A: The projected valuation for 2035 is $53.91 Million.

**Q: What is the expected CAGR for the Spain extracorporeal membrane-oxygenation-machine market during the forecast period 2025 - 2035?**
A: The expected CAGR is 6.15% during the forecast period.

**Q: Which application segments are driving the extracorporeal membrane-oxygenation-machine market in Spain?**
A: Key application segments include Cardiac Support, Respiratory Support, and Cardiopulmonary Bypass.

**Q: What were the market values for the Cardiac Support application in 2024 and its projected value in 2035?**
A: The market value for Cardiac Support was $8.39 Million in 2024 and is projected to reach $16.25 Million by 2035.

**Q: How do the end-user segments for the extracorporeal membrane-oxygenation-machine market in Spain compare?**
A: End-user segments include Hospitals, Ambulatory Surgical Centers, and Home Care Settings, with Hospitals valued at $15.0 Million in 2024.

**Q: What are the key product types in the Spain extracorporeal membrane-oxygenation-machine market?**
A: Key product types include Venoarterial ECMO, Venovenous ECMO, and Arteriovenous ECMO.

**Q: What were the market values for Venovenous ECMO in 2024 and its projected value in 2035?**
A: The market value for Venovenous ECMO was $12.0 Million in 2024 and is projected to reach $24.0 Million by 2035.

**Q: Which companies are considered key players in the Spain extracorporeal membrane-oxygenation-machine market?**
A: Key players include Medtronic, Getinge, LivaNova, Fresenius SE, Terumo Corporation, Maquet, Nipro Corporation, and Xenios AG.

**Q: What components are essential in the extracorporeal membrane-oxygenation-machine market in Spain?**
A: Essential components include Membrane Oxygenators, Blood Pumps, and Heat Exchangers, with Membrane Oxygenators valued at $10.0 Million in 2024.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/spain-extracorporeal-membrane-oxygenation-machine-market-50836*